4//SEC Filing
Durata Therapeutics, Inc. 4
Accession 0000904454-14-000755
CIK 0001544116operating
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 12:06 PM ET
Size
15.3 KB
Accession
0000904454-14-000755
Insider Transaction Report
Form 4
BLAIR JAMES C
10% Owner
Transactions
- Disposition to Issuer
Common Stock
2014-11-17−6,250→ 0 total
VITULLO NICOLE
Director10% Owner
Transactions
- Disposition to Issuer
Common Stock
2014-11-17−6,250→ 0 total
Halak Brian K
10% Owner
Transactions
- Disposition to Issuer
Common Stock
2014-11-17−6,250→ 0 total
TREU JESSE I
10% Owner
Transactions
- Disposition to Issuer
Common Stock
2014-11-17−6,250→ 0 total
SCHOEMAKER KATHLEEN K
10% Owner
Transactions
- Disposition to Issuer
Common Stock
2014-11-17−6,250→ 0 total
Kamdar Kim P.
10% Owner
Transactions
- Disposition to Issuer
Common Stock
2014-11-17−6,250→ 0 total
DOVEY BRIAN H
10% Owner
Transactions
- Disposition to Issuer
Common Stock
2014-11-17−6,250→ 0 total
DOMAIN ASSOCIATES
10% Owner
Transactions
- Disposition to Issuer
Common Stock
2014-11-17−6,250→ 0 total
Footnotes (4)
- [F1]The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.
- [F2]As managing members of the sole general partner of DP VIII Associates, L.P., each Reporting Owner listed below (except for Kim P. Kamdar) may also be deemed to indirectly beneficially own the securities of the Issuer held by DP VIII Associates, L.P. reported on a Form 4 for DP VIII Associates, L.P. filed on the same date as this Form 4.
- [F3]As managing members of the sole general partner of Domain Partners VIII, L.P., each Reporting Owner listed below (except for Kim P. Kamdar) may also be deemed to indirectly beneficially own the securities of the Issuer held by Domain Partners VIII, L.P. reported on a Form 4 for Domain Partners VIII, L.P. filed on the same date as this Form 4.
- [F4]Pursuant to the terms of the Agreement and Plan of Merger, dated as of October 5, 2014, by and among Durata Therapeutics, Inc., Actavis W.C. Holding Inc., and Delaware Merger Sub, Inc. (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), each share of Durata common stock was validly tendered for $23 per share in cash plus one non-transferable contingent value right for each share (each a "CVR"), which represents the contractual right to receive up to $5.00 per share upon the achievement of certain milestones, subject to any required withholding of taxes.
Documents
Issuer
Durata Therapeutics, Inc.
CIK 0001544116
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001544116
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 12:06 PM ET
- Size
- 15.3 KB